102 -2 (40) 2022 — Abdurakhmanov M.M., Eshonov O.Sh., — MECHANISMS OF THE DEVELOPMENT OF COAGULOPATHY IN COVID-19.

MECHANISMS OF THE DEVELOPMENT OF COAGULOPATHY IN COVID-19.

Abdurakhmanov M.M., Bukhara State Medical Institute

Eshonov O.Sh., Bukhara State Medical Institute

Abdurakhmanov Z.M., Bukhara State Medical Institute

Tagaeva X.D., Bukhara State Medical Institute

Kayumov M.T. Bukhara State Medical Institute

Resume

The objective difficulties that arise in the management of patients with SARS-CoV-2 infection have raised many questions. At the initial stage of patient management, there often comes a moment of sudden clinical exacerbation of the disease with the establishment of a chain of events that gradually worsens to a possible fatal outcome, despite optimal treatment. Gradually, it became clear that the pathological manifestation of the infection is not only viral pneumonia, which causes severe respiratory failure, but also a hypercoagulable state. The molecular mechanisms underlying the hypercoagulability observed in patients with COVID-19 suggest a strong relationship with inflammation. This article summarizes the current data of published studies covering the pathogenesis, clinical and laboratory features of the treatment of COVID-19 associated coagulopathy.

Keywords: COVID-19, coagulopathy

First page

518

Last page

521

For citation: Abdurakhmanov M.M., Eshonov O.Sh.,Abdurakhmanov Z.M., Tagaeva X.D., Kayumov M.T. MECHANISMS OF THE DEVELOPMENT OF COAGULOPATHY IN COVID-19. //New Day in Medicine 2(40)2022 518-521 https://clck.ru/eYt4Q

LIST OF REFERENCES:

1. Анаев Э.Х. идр. Коагулопатия при COVID-19: фокус на антикоагулянтную терапию / Э.Х. Анаев, Н.П. Княжеская. – Текст: непосредственный // Практическая пульмонология. – 2020. – № 1 – С. 3 – 13.
2. Временные методические рекомендации. «Профилактика, диагностика и лечение новой коронавирусной инфекции COVID-19». Версии 11. – Москва, 2021. – Текст: непосредственный.
3. Галстян Г.М.Коагулопатия при COVID-19 / Г.М. Галстян. – Текст: непосредственный //Пульмонология. – 2020. – Т. 30, № 5. – C. 645 – 657.
4. Явелов И.С.COVID-19: состояние системы гемостаза и особенности антитромботической терапии / И.С. Явелов, О.М. Драпкина. – Текст: непосредственный // Кардиоваскулярная терапия и профилактика. – 2020 – T. 19, № 3. – С. 310 – 318.
5. Angiotensin II signal transduction: an update on mechanisms of physiology and pathophysiology / S. Forrester, G. Booz, C. Sigmund [et al.]. – Text (visual): unmediated // Physiol Rev. – 2018. – Vol. 98. – P. 1627 – 1738.
6. Y. Zhang et al. Coagulopathy and antiphospholipid antibodies in patients with Covid-19 / Y. Zhang, M. Xiao, S. Shulan Zhang [et al.]. – Text (visual): unmediated // N. Engl. J. Med. – 2020. – Р. 38.
7. M. Paz Ocaranza et al. Counterregulatory renin – angiotensin system in cardiovascular disease / M. Paz Ocaranza, J. Riquelme, L. Garc´ıa [et al.]. – Text (visual): unmediated // Nat Rev Cardiol. – 2020. – Vol. 17. – P. 116 – 129.
8. COVID-19-Associated Coagulopathy: An Exacerbated Immunothrombosis Response / Apoorva Jayarangaiah [et al.]. – Text (visual): unmediated // Clin Appl Thromb Hemost. – 2020. – Vol. 26: 1076029620943293.
9. Colling M.COVID-19-associated coagulopathy: An exploration of mechanisms. / M. Colling, Y. Kanthi. – Text (visual): unmediated // Vascular Medicine. – 2020. – Vol. 25. – P. 471 – 478
10. Frantzeskaki F. Immunothrombosis in acute respiratory distress syndrome: Cross talks between inflammation and coagulation. / F. Frantzeskaki, A. Armaganidis, S. Orfanos. – Text (visual): unmediated // Respiration. – 2017. –Vol. 93. – P. 212 – 225.
11. Monocytes, neutrophils, and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo / M. von Bruhl, K. Stark, A. Steinhart [et al.]. – Text (visual) : unmediated // J Exp Med. – 2012. – Vol. 209. – P. 819 – 835.
12. SARS, MERS, and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned? / N. Peeri, N. Shrestha, M. S. Rahman [et al.]. – Text (visual): unmediated // Int J Epidemiol. – 2020. – Vol. 49 – P. 717 – 726.
13. Swystun L.The role of leukocytes in thrombosis / L. Swystun, P. Liaw. – Text (visual): unmediated // Blood. – 2016. – Vol. 128. – P.753 – 762.
14. Oblokulov, A.R., Niyozov, G.E. Clinical and epidemiological characteristics of patients with COVID-19 (2020) International Journal of Pharmaceutical Research, 12 (4), pp. 3749-3752.